TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) of $0 for the 9-month period ending 2017-09-30, per its 6-K filed 2017-11-02.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome · last filed 2017-11-02
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in other comprehensive income (loss) for the quarter ending 2017-09-30 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) 0 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | $0.00 6-K · filed 2017-11-02 | ||
| 2017-06-30 | $0.00 6-K · filed 2017-08-03 | |||
| 2017-03-31 | $0.00 6-K · filed 2017-05-11 | |||
| 2016-03-31 | -$1.00M 6-K · filed 2016-05-09 |